首页> Leukemia & lymphoma> A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tony,Reiman

第一单位： a Department of oncology, Saint John Regional Hospital , Dalhousie University, and University of New Brunswick , Saint John , Canada.

作者： Tony,Reiman ^[1] ; Kerry J,Savage ^[2] ; Michael,Crump ^[3] ; Matthew C,Cheung ^[4] ; David,MacDonald ^[5] ; Rena,Buckstein ^[4] ; Stephen,Couban ^[5] ; Eugenia,Piliotis ^[4] ; Kevin,Imrie ^[6] ; David,Spaner ^[4] ; Sudeep,Shivakumar ^[5] ; John,Kuruvilla ^[3] ; Diego,Villa ^[7] ; Lois E,Shepherd ^[7] ; Tanya,Skamene ^[7] ; Chad,Winch ^[7] ; Bingshu E,Chen ^[7] ; Annette E,Hay ^[7]

作者单位： a Department of oncology, Saint John Regional Hospital , Dalhousie University, and University of New Brunswick , Saint John , Canada. ^[1] b BC Cancer Agency , Vancouver , Canada. ^[2] c Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre , Toronto , Canada. ^[3] d Division of Hematology, Sunnybrook Health Services Centre , Toronto , Canada. ^[4] e Department of Hematology, QEII Health Sciences Centre , Halifax , Canada. ^[5] f Department of Hematology, Sunnybrook Health Services Centre , Toronto , Canada. ^[6] g Canadian Cancer Trials Group, Cancer Research Institute , Queen's University , Kingston , Canada. ^[7]

关键词 Non-Hodgkin lymphoma combination therapy phase I trial romidepsin